NESTcc Announces 12 New Real-World Evidence Test-Cases

Today, NESTcc announced 12 new Real-World Evidence (RWE) Test-Cases.  These projects will answer questions of importance to the medical device ecosystem through collaborations between NESTcc Network Collaborators and submitting organizations, including health systems, government organizations, non-profit patient organizations, and medical device manufacturers.  NESTcc’s Test-Case portfolio now includes 20 projects that span the Total Project Life […]


NESTcc to Solicit Public Comments on Data Quality and Methods Protocol Frameworks

In June 2018, NESTcc established multi-stakeholder Data Quality and Methods Subcommittees, which have been working diligently on the NESTcc Data Quality and Methods Protocol Frameworks.  NESTcc will be releasing initial versions of these Frameworks for public comment on Tuesday, May 28, 2019.  The public comment period will be open until Friday, June 21, 2019. NESTcc […]


NESTcc Governing Committee Welcomes Jennifer Luray, MPA of Research!America

NESTcc is pleased to announce that on February 12, 2019, the MDIC Board of Directors confirmed Jennifer Luray, MPA as the newest member of NESTcc’s Governing Committee.  Ms. Luray serves as Senior Advisor at Research!America and has a background working in the medical device industry, the patient community, and government.  Mary Woolley, President & CEO […]


NESTcc Establishes Active Surveillance Task Force

On December 13, 2018, the NESTcc Governing Committee approved the establishment of a small, multi-stakeholder Active Surveillance Task Force tasked with establishing a blueprint for leveraging NESTcc’s work to advance active surveillance and subsequently launch NESTcc’s first active surveillance projects.  The Task Force will develop a blueprint by Spring 2019, and the first active surveillance […]


Developing the NESTcc Active Surveillance Portfolio

In 2016, the National Evaluation System for health Technology Coordinating Center (NESTcc) was established, in part, to help address the timely and robust identification of safety signals for medical devices.  NESTcc has received dedicated funding from the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) to advance active surveillance activities […]